| Trial ID: | L6518 |
| Source ID: | NCT00712478
|
| Associated Drug: |
Insulin
|
| Title: |
Observational Study Describing Conditions for Intensification of Insulin Therapy in Type 2 Diabetes
|
| Acronym: |
INTENSE3MIX
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes|Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: insulin
|
| Outcome Measures: |
Primary: Evaluate improvement of diabetes control with fasting glycemia and after diner glycemia measurements, After 3 months | Secondary: Evaluate improvement of diabetes control with fasting glycemia and after diner glycemia measurements, After first 2 months
|
| Sponsor/Collaborators: |
Sponsor: Novo Nordisk A/S
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
114
|
| Study Type: |
OBSERVATIONAL
|
| Study Designs: |
Observational Model: |Time Perspective: p
|
| Start Date: |
2007-09
|
| Completion Date: |
2009-03
|
| Results First Posted: |
|
| Last Update Posted: |
2023-11-02
|
| Locations: |
Paris La Défense, 92936, France
|
| URL: |
https://clinicaltrials.gov/show/NCT00712478
|
